0001225208-16-028376.txt : 20160226
0001225208-16-028376.hdr.sgml : 20160226
20160226150506
ACCESSION NUMBER: 0001225208-16-028376
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160224
FILED AS OF DATE: 20160226
DATE AS OF CHANGE: 20160226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CANGIALOSI LORETTA V
CENTRAL INDEX KEY: 0001174449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 161460918
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY
STREET 2: 235 EAST 42ND ST.
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4.xml
X0306
4
2016-02-24
0000078003
PFIZER INC
PFE
0001174449
CANGIALOSI LORETTA V
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Sr. Vice President, Controller
Common Stock
2016-02-24
4
M
0
34171.0000
18.9000
A
210943.0000
D
Common Stock
2016-02-24
4
F
0
6713.0000
30.0200
D
204230.0000
D
Common Stock
2016-02-24
4
F
0
16124.0000
29.6700
D
188106.0000
D
Common Stock
2016-02-25
4
A
0
4992.0000
0.0000
A
193098.0000
D
Common Stock
811.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
18.9000
2016-02-24
4
M
0
34171.0000
0.0000
D
2016-02-24
2016-02-24
Common Stock
34171.0000
0.0000
D
Stock Appreciation Rights
30.5900
2016-02-25
4
A
0
25862.0000
0.0000
A
2021-02-25
2021-02-25
Common Stock
25862.0000
25862.0000
D
Stock Appreciation Rights
30.5900
2016-02-25
4
A
0
23112.0000
0.0000
A
2023-02-25
2023-02-25
Common Stock
23112.0000
23112.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Susan E. Grant, by power of atty., for Loretta V. Cangialosi
2016-02-26